Q2 2026 13F · SEC CIK 1692590
Vitruvian Partners LLP
Hedge fundFiled 2026-08-10 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $201.0M
- Reported positions
- 8
- Top holdings a year, 3 yrs
- +24.7%
- Average holding period
- 4.0 yrs
Vitruvian Partners LLP is a hedge fund that reported 8 positions worth $201.0M in its Q2 2026 13F, filed 2026-08-10. Its largest holdings were Marqeta, Inc. (MQ, 55.4%), Hinge Health, Inc. (HNGE, 20.9%), Xometry, Inc. (XMTR, 8.7%). A portfolio copying its top holdings returned 24.7% a year over the last 3 years, against 20.4% for the S&P 500.
Vitruvian Partners LLP holdings all 8 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| MQMarqeta, Inc. | 55.4% | +0.0% | $111.3M |
| HNGEHinge Health, Inc. | 20.9% | -59.5% | $42.0M |
| XMTRXometry, Inc. | 8.7% | -5.6% | $17.5M |
| CARGCargurus Inc | 5.9% | -26.0% | $11.9M |
| GLBEGlobal E Online Ltd | 3.6% | +0.0% | $7.3M |
| MXCTMaxcyte Inc | 3.1% | +0.0% | $6.2M |
| WPLCFWise Group PLC | 1.7% | — | $3.4M |
| RXSTRxsight Inc | 0.7% | +0.0% | $1.3M |
What Vitruvian Partners LLP bought and sold in Q2 2026, against Q1 2026.
New positions
- WPLCF Wise Group PLC1.7% of 13F
Added to
No position grew by more than 5%.
Reduced
- HNGE Hinge Health, Inc.-59.5% shares
- CARG Cargurus Inc-26.0% shares
- XMTR Xometry, Inc.-5.6% shares
Sold out
Nothing sold out.
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +23.5% /yr
- S&P 500 +20.1%
- 3 years
- +24.7% /yr
- S&P 500 +20.4%
- 5 years
- -5.4% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $201.0M | 8 |
| Q1 2026 | $111.8M | 7 |
| Q4 2025 | $139.2M | 7 |
| Q3 2025 | $144.2M | 7 |
| Q2 2025 | $164.2M | 7 |
| Q1 2025 | $104.8M | 6 |
| Q4 2024 | $116.2M | 6 |
| Q3 2024 | $257.5M | 6 |
| Q2 2024 | $340.7M | 8 |
| Q1 2024 | $315.4M | 8 |
| Q4 2023 | $393.5M | 9 |
| Q3 2023 | $352.6M | 10 |
Questions about Vitruvian Partners LLP's portfolio
What stocks does Vitruvian Partners LLP own?
Vitruvian Partners LLP's latest 13F, for Q2 2026 and filed Aug 10, 2026, lists 8 positions worth $201.0M. The largest are Marqeta, Inc. (MQ) at 55.4%, Hinge Health, Inc. (HNGE) at 20.9%, Xometry, Inc. (XMTR) at 8.7%, Cargurus Inc (CARG) at 5.9% and Global E Online Ltd (GLBE) at 3.6%.
What did Vitruvian Partners LLP buy last quarter?
In Q2 2026, Vitruvian Partners LLP added a new position in Wise Group PLC (WPLCF), compared with its Q1 2026 filing.
What did Vitruvian Partners LLP sell last quarter?
In Q2 2026, Vitruvian Partners LLP Hinge Health, Inc. (HNGE) (-59.5% shares), Cargurus Inc (CARG) (-26.0% shares) and Xometry, Inc. (XMTR) (-5.6% shares), compared with its Q1 2026 filing.
How has Vitruvian Partners LLP's portfolio performed?
A portfolio copying Vitruvian Partners LLP's 20 largest 13F holdings each quarter, from the day each filing was public, returned +24.7% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +23.5% against +20.1%. Over 5 years: -5.4% a year against +11.6%.
When is Vitruvian Partners LLP's next 13F filing due?
13F filings are due 45 days after each quarter ends. Vitruvian Partners LLP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.